Bank of America’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-30,000
Closed -$5.39M 8104
2023
Q4
$5.39M Sell
30,000
-1,400
-4% -$218K ﹤0.01% 3488
2023
Q3
$4.99M Buy
+31,400
New +$5.13M ﹤0.01% 3410

Other funds holding RGEN

Bank of America's RGEN Position: Q1 2026 in Review

Bank of America reduced its Repligen (RGEN) stake by 4.8% in Q1 2026, selling an estimated $2.66M and leaving 378,205 shares worth $44.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Bank of America first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $171M in Q3 2021. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Bank of America held 378,205 shares of Repligen worth $44.6M as of Q1 2026.
  • Bank of America sold 19,024 Repligen shares in Q1 2026, an estimated $2.66M.
  • Repligen made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1680 holding.
  • Bank of America first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Repligen position peaked at $171M in Q3 2021.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.